Cipemastat Explained

Cipemastat (rINN, also known as Ro 32-3555 and by the tentative trade name Trocade) is a selective inhibitor of matrix metalloproteinase-1 that has been investigated as an anti-arthritis agent.[1] It is being developed by Roche.

References

  1. Hemmings F, Farhan M, Rowland J, Banken L, Jain R . Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis . Rheumatology (Oxford) . 40 . 5 . 537–43 . 2001 . 11371662 . 10.1093/rheumatology/40.5.537. free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Cipemastat".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.